What it is best to know: – InStride Well being, a frontrunner in outpatient therapy for pediatric anxiousness and OCD, closes its oversubscribed $30 million Sequence B financing spherical led by Normal Catalyst with participation from current buyers .406 Ventures, Valtruis, Mass Normal Brigham Ventures and Hopelab Basis. – The most recent funding brings InStride Well being's complete funding to […]
